Posts

Showing posts from October, 2021

MedTech Industry Outlook in the GCC Countries

The Covid-19 outbreak has severely impacted the global economy. Like other countries, the GCC countries have also experienced a significant impact on various industries including the MedTech sector. It has hampered the demand of the patients and customers for medical devices and services. While the demand for the PPEs, COVID 19 diagnostic kits, telemedicine, and remote engagement services, has touched a new height. To support the MedTech industry, governments in the GCC have initiated several measures such as launching social infrastructure projects, the introduction of smart monitors and AI-associated medical devices, adoption of wearable technologies among patients, providing access to the COVID-19 combating devices, ease in guidelines related to medical devices, and introduction to innovative electronic platforms, among several others.  Analyzing the trend over the past few years before Covid-19, the GCC countries have made rapid advancements in the MedTech industry. During the...

What is Achondroplasia Treatment Market?

Achondroplasia is the most common of skeletal dysplasia that results in marked short stature (dwarfism). It is a human bone genetic disorder of the growth plate and is the most common form of inherited disproportionate short stature. DelveInsight's " Achondroplasia Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some facts of Achondroplasia Market Report are: ·          According to Columbia University Medical Center (CUMC), this disorder occurs in approximately 1 in 25,000 live births worldwide. ·          The prevelance rates have correlation to father’s age as mutations occur exclusively in the male and older men who have a higher probability of ...

What is Acute Coronary Syndrome Treatment Market?

Acute Coronary Syndrome is an umbrella term that refers to a spectrum of conditions compatible with acute myocardial ischemia and/or infarction that are usually due to an abrupt reduction in coronary blood flow. The traditional types of Acute Coronary Syndrome comprise of myocardial infarction with ST-segment elevation (STEMI), which generally reflects an acute total coronary occlusion, myocardial infarction without ST-segment elevation (NSTEMI), and unstable angina (UA), with or without myocardial injury, respectively. DelveInsight's Acute Coronary Syndrome Market Insights, Epidemiology, and Market Forecast-2030  report delivers an in-depth understanding of the Acute Coronary Syndrome, historical and forecasted epidemiology as well as the Acute Coronary Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some facts of Acute Coronary Syndrome Market are: ·          As per ...

Chronic Cutaneous Ulcer Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

Chronic Cutaneous Ulcers are wounds that do not heal through an orderly and timely reparation, which in turn, hinders the production of anatomic and functional integrity. This can also be re-defined as “interruption on the continuity of the body's tissue that requires a prolonged time to heal, does not heal, or recurs.” DelveInsight's  " Chronic Cutaneous Ulcer Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Chronic Cutaneous Ulcer, historical and forecasted epidemiology as well as the Chronic Cutaneous Ulcer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Chronic Ulcers are mainly caused by conditions that slow or stop the healing process, such as inadequate blood supply or low oxygen, an infection, weak immune system, swelling in the tissues around the wound. These are mainly classified as vascular ulcers (e.g., venous and arterial ulcers), diabeti...

X-linked hypophosphatemia Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

X-linked hypophosphatemia is a hereditary renal phosphate-wasting disorder characterized by hypophosphatemia, rickets and/or osteomalacia, and diminished growth. Phosphate levels are low because phosphate is abnormally processed in the kidneys, which causes a loss of phosphate in the urine (phosphate wasting) and leads to soft, weak bones (rickets). XLH is usually diagnosed in childhood. Features include bowed or bent legs, short stature, bone pain, and severe dental pain. XLH is the most common form of hereditary hypophosphatemic rickets. DelveInsight's  " X Linked Hypophosphatemia Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the X Linked Hypophosphatemia, historical and forecasted epidemiology as well as the X Linked Hypophosphatemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some facts of X Linked Hypophosphatemia Market Report are: ·   ...